Lung Cancer

Tecemotide (INN; emepepimut-S (USAN); formerly known as BLP25 or EMD 531444) is a synthetic lipopeptide that is used as antigen in an investigational therapeutic cancer vaccine (formerly known as Stimuvax, L-BLP25, BLP25 liposomal vaccine, or BLP25 liposome vaccine).

Read more in the app

Here’s how air pollution may trigger lung cancer

Air Pollution 'Strongly Associated' With DNA Mutations Tied to Lung Cancer

Scientists discover protein that helps lung cancer spread to the brain - EurekAlert!

Air pollution may contribute to development of lung cancer in never-smokers, new study finds - EurekAlert!

Effect of respiratory phase on three-dimensional quantitative parameters of pulmonary subsolid nodules in low-dose computed tomography screening for lung cancer - EurekAlert!

New Hope for Lung Cancer: Scientists Develop Targeted Genetic Treatment

Smart nanoparticles launch genetic attack on lung cancer and cystic fibrosis

New biomarker may guide best use of KRAS inhibitors in lung cancer - EurekAlert!

Identifying lung cancer in Emergency Department patients outside national lung cancer screening guidelines - EurekAlert!

NRG Oncology adds new committee leaders in lung cancer and imaging - EurekAlert!

Detecting lung cancer 4 months earlier at the GP using artificial intelligence - EurekAlert!

Unraveling the oncogenic potential of microRNAs in lung cancer - EurekAlert!

Scientists Discover Unexpected Link Between Diet And Lung Cancer Risk

Eat better, breathe easier? Research points to link between diet, lung cancer - EurekAlert

Eat better, breathe easier? Research points to link between diet, lung cancer

Breakthrough combination therapy tackles drug resistance in lung cancer with common KRAS mutation - EurekAlert

Lung Cancer Is Rising in Non-Smokers, And This Could Be Why

Research pinpoints weakness in lung cancer's defenses

Copper-detection tool designed to discover possible chelation target for lung cancer

Princeton Chemistry develops copper-detection tool to discover possible chelation target for lung cancer - EurekAlert